Results 31 to 40 of about 189,589 (267)

Comparison of conservative treatment versus transcatheter arterial embolisation for the treatment of spontaneously ruptured hepatocellular carcinoma [PDF]

open access: yes, 2018
Purpose: To elucidate the prognostic factors in the spontaneous rupture of hepatocellular carcinoma (HCC) and to determine whether transcatheter arterial embolisation (TAE) is associated with better prognosis compared to conservative treatment.
Baba, Yasutaka   +8 more
core   +1 more source

Portal Vein Thrombosis: State-of-the-Art Review

open access: yesJournal of Clinical Medicine
Background: Portal vein thrombosis (PVT) is a rare disease with an estimated incidence of 2 to 4 cases per 100,000 inhabitants. The most common predisposing conditions for PVT are chronic liver diseases (cirrhosis), primary or secondary hepatobiliary ...
A. Boccatonda   +8 more
semanticscholar   +1 more source

Aszites, Pfortaderthrombose und hepatische Enzephalopathie bei Leberzirrhose: Aktuelle Therapieempfehlungen [PDF]

open access: yes, 2012
Treatment of Ascites, Portal Vein Thrombosis and Hepatic Encephalopathy in Patients with Cirrhosis of the Liver Background: Ascites, portal vein thrombosis and hepatic encephalopathy are important complications of cirrhosis of the liver.
Abecasis R   +46 more
core   +1 more source

Giant extra-hepatic thrombosed portal vein aneurysm: a case report and review of the literature. [PDF]

open access: yes, 2014
BACKGROUND: Extrahepatic Portal vein aneurysm (EPVA) is a rare finding that may be associated with different complications, e.g. thrombosis, rupture, portal hypertension and compression of adjacent structures.
Allemann, P.   +4 more
core   +2 more sources

Distal Splenorenal Shunt for Portal Vein Thrombosis after Liver Transplantation [PDF]

open access: yes, 1989
A 17‐yr‐oId female received a liver transplant for type I glycogen storage disease. A year later, when she experienced variceal gastrointestinal hemorrhage, an angiogram revealed thrombosis of the portal vein with hepatopetal collateral channels.
Esquivel, CO   +6 more
core   +1 more source

A prospective, multicentre study in acute non‐cirrhotic, non‐malignant portal vein thrombosis: comparison of medical and interventional treatment

open access: yesAlimentary Pharmacology and Therapeutics, 2020
To evaluate medical versus interventional treatment (transjugular thrombus fragmentation, local thrombolysis with or without stent implantation) in patients with acute non‐cirrhotic, non‐malignant portal vein thrombosis (PVT).
M. Rössle   +25 more
semanticscholar   +1 more source

A Rare Complication of Acute Appendicitis: Superior Mesenteric Vein Thrombosis [PDF]

open access: yes, 2016
Superior mesenteric vein (SMV) thrombosis caused by acute appendicitis is quite rare nowadays. These conditions occurs secondary to infection in the region drained by the portal venous system.
Johan, M. M. (Maisie)   +2 more
core   +3 more sources

Microvascular Health as a Key Determinant of Organismal Aging

open access: yesAdvanced Science, EarlyView.
This review spotlights the emerging field of vascular aging, providing a comprehensive and critical overview of the molecular processes and clinical manifestations of vascular dysfunction during aging. By combining basic angioscience concepts with a critical analysis of innovative pre‐clinical aging models and lifestyle interventions, it offers a ...
Mattia Cenciarini   +4 more
wiley   +1 more source

Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case Report

open access: yesAmerican Journal of Gastroenterology, 2020
INTRODUCTION Abdominal pain and hypertransaminasemia are gastrointestinal symptoms reported in approximately 10% and in more than 20% of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, respectively (1,2).
V. la Mura   +10 more
semanticscholar   +1 more source

Therapeutic Reprogramming of Glioblastoma Phenotypic States Using Multifunctional Heparin Nanoparticles

open access: yesAdvanced Science, EarlyView.
This study presents heparin‐derived nanoparticles (HP‐NPs) as a novel precision medicine platform that combines therapeutic and delivery functions. HP‐NPs target drug‐resistant glioblastoma stem cells, reprogramming them into a drug‐sensitive phenotype and significantly reducing tumor progression.
Vadim Le Joncour   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy